Analysts Viewpoint Recent Insider Activity Could Benefit Acumen Pharmaceuticals Inc (ABOS) Acumen Pharmaceuticals Inc’s recently made public that its CFO & Chief Business Officer Zuga Matt unloaded Company’s shares for reported
Analysts Viewpoint A company insider recently sold 28,902 shares of Acumen Pharmaceuticals Inc [ABOS]. Should You also Consider to Sale? In a filing, Acumen Pharmaceuticals Inc revealed its CFO & Chief Business Officer Zuga Matt unloaded Company’s shares for reported
Stock Earnings Potential Price Increase for Acumen Pharmaceuticals Inc (ABOS) After Recent Insider Activity Acumen Pharmaceuticals Inc’s filing revealed that its CFO & Chief Business Officer Zuga Matt unloaded Company’s shares for reported $49633.0